Bufferin (Acetaminophen)

Quick links to important sections

Bufferin (Acetaminophen)

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Bufferin (Acetaminophen)

Property Description
Active Ingredient Acetaminophen (also known as Paracetamol)
Common Form Oral tablets, capsules, liquid suspensions
Pharmacological Class Analgesic (Pain Reliever) & Antipyretic (Fever Reducer)
Common Use Relief of mild-to-moderate pain and reduction of fever
Origin Synthetic chemical compound

The Identity and Composition

Acetaminophen is the internationally recognized name (INN) for this commonly used chemical substance, often known as paracetamol outside of the U.S. It is a widely available over-the-counter (OTC) medication, classified chemically as a p-aminophenol derivative with the molecular formula C8H9NO2. Although the Bufferin brand name is historically associated with aspirin in the U.S. market, products in the Bufferin family across various global regions frequently incorporate acetaminophen into their formulations, recognizing its value as a core pain reliever.


The Pharmacological Class and General Purpose

Acetaminophen is classified primarily as an analgesic and an antipyretic agent, defining its two main therapeutic roles: pain relief and fever reduction. This designation means the medication works to address two of the most common physical symptoms of illness and injury, and it is a fundamental option for symptomatic relief globally.

Unlike non-steroidal anti-inflammatory drugs (NSAIDs) such as aspirin or ibuprofen, acetaminophen's mechanism of action focuses on the central nervous system, and it is not typically used to treat swelling or local inflammation. The medication’s core therapeutic purpose is to provide temporary and effective relief from mild to moderate aches and pains and to reduce an elevated body temperature associated with common ailments like headaches and colds.

Regulatory References

  1. NIH StatPearls: Acetaminophen

What side effects are possible with Bufferin (Acetaminophen)?

Possible Side Effects and Safety Information

This information describes the documented safety profile of acetaminophen as specified in official government regulatory materials, and does not include advice or dosing instructions.

Serious Adverse Reactions and Warnings

Official labeling includes mandatory warnings regarding serious hepatotoxicity (liver damage). This risk includes the potential for severe liver failure and death. Taking more than the recommended daily dose or consuming three or more alcoholic drinks daily significantly increases this risk.

An Allergy Alert is also required, as acetaminophen use has been associated with rare but severe, and potentially fatal, serious skin reactions. These include Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), and Acute Generalized Exanthematous Pustulosis (AGEP).

Adverse Reaction Categories

Adverse reactions are classified in regulatory documents according to the body systems affected and their frequency, when known.

System-Organ Class Frequency Examples (Selected)
Hepatobiliary Disorders Not known Liver failure, Hepatotoxicity
Skin and Subcutaneous Tissue Disorders Not known SJS, TEN, AGEP
Blood and Lymphatic System Disorders Rare Thrombocytopenia, Agranulocytosis
Immune System Disorders Rare Hypersensitivity reactions

Population and Exposure Considerations

The risk of liver damage is elevated in certain patient groups, including those with pre-existing hepatic impairment, active liver disease, chronic malnutrition, or alcoholism. The official safety profile restricts use in situations where risk is increased, such as taking the medicine concurrently with other acetaminophen-containing products.

Overdose and Emergency Response

Overdose and When to Seek Help

Regulatory authorities classify acetaminophen overdose as a potentially life-threatening adverse event. Immediate medical attention is critical for adults and children who have ingested an overdose dose, even if no signs or symptoms are noticed. Official guidance mandates immediately contacting emergency services or proceeding to a hospital emergency department upon suspected over-ingestion.

The clinical presentation of overdose is often delayed. Initial non-specific manifestations commonly include nausea, vomiting, anorexia (loss of appetite), diaphoresis (sweating), malaise, and pallor. The primary documented risk is dose-dependent severe hepatic damage, which can progress to hepatic failure and ultimately death. Later clinical signs can include jaundice and tender hepatomegaly, supported by laboratory findings like elevated serum aminotransferases and prolonged Prothrombin Time. Acute renal tubular necrosis is also a documented severe outcome.

The specific antidote officially documented for acetaminophen toxicity is Acetylcysteine (N-acetylcysteine). Required management procedures include the use of activated charcoal in appropriate circumstances, symptomatic and supportive treatment, prolonged hospitalization, and close clinical and laboratory monitoring of liver function. Individuals with pre-existing hepatic impairment or chronic heavy alcohol consumption are noted to be at increased risk of severe toxicity.

Therapeutic Uses of Bufferin (Acetaminophen)

Quick Facts: Uses of Acetaminophen

  • Assists with: Temporary relief of mild to moderate pain.
  • Addresses: Common headaches, muscle aches, and backaches.
  • Helps reduce: Fever associated with various conditions.

Bufferin (Acetaminophen) is a widely available medication indicated for two primary therapeutic domains: pain relief and fever reduction. It is a common first-line option to manage minor aches and discomforts, which may be associated with conditions such as the common cold, toothaches, or mild pain of arthritis.

Acetaminophen is utilized to temporarily manage and reduce the experience of pain across multiple body areas, including the head, muscles, and back. Additionally, the medication serves the purpose of reducing elevated body temperature, which is a symptom of various illnesses. This therapeutic profile characterizes the medication's primary application.

Eligibility and Restrictions for Use

Who Can and Cannot Use Bufferin (Acetaminophen)?

This section details the population eligibility and non-eligibility criteria based strictly on official regulatory documents.

Category Eligibility Constraint or Status
Contraindicated Populations Individuals with a known hypersensitivity or allergy to acetaminophen or any formulation excipients.
Patients diagnosed with severe hepatic impairment or severe active liver disease.
Age-Related Rules Adults and adolescents are eligible under standard conditions. Use in children under 2 years of age for many Over-The-Counter products is not recommended without the direction of a healthcare provider.
Condition-Specific Restrictions Severe renal impairment requires caution and may necessitate changes to treatment frequency. Caution is also required for patients with non-severe hepatic impairment, alcoholism, chronic malnutrition, or severe hypovolemia.
Pregnancy and Lactation Pregnancy: Use is permitted only at the lowest effective dose for the shortest duration. Lactation: Use at therapeutic doses is generally considered acceptable.

Connection to the overall eligibility profile: Regulatory bodies define non-eligibility through absolute contraindications related to allergic response and severe organ damage. For populations with existing conditions like moderate hepatic or renal impairment, or during pregnancy, eligibility is conditional, requiring restricted use or special professional consideration, as documented in the product labeling.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information identifies specific drug classes and substances that can interact with acetaminophen, necessitating caution or monitoring. The most critical constraint is the restriction to not use this product with any other prescription or non-prescription medicine containing acetaminophen to prevent severe liver damage.

Documented Interactions and Implications

Interacting Product Category Practical Implication based on Regulatory Data
Oral Anticoagulants (e.g., Warfarin) Acetaminophen may enhance the effect of these medicines. If used concurrently, especially at higher doses or long-term, close monitoring of prothrombin time or INR is required, as the anticoagulant dose may need adjustment.
Cholestyramine This medicine may reduce the absorption of acetaminophen. Regulatory guidance requires at least one hour to elapse between administering Cholestyramine and acetaminophen.
Alcohol (Ethanol) Chronic consumption of three or more alcoholic drinks per day significantly increases the risk of severe liver toxicity from acetaminophen. Use should be approached cautiously in this population.
Enzyme Inducers Certain medications that induce hepatic enzymes (e.g., specific anticonvulsants or antitubercular agents) may increase the risk of acetaminophen-related liver toxicity.

The official profile centers on preventing additive liver toxicity and managing altered medication effects. The enhancement of the oral anticoagulant effect is a clinically significant interaction that mandates professional consultation and coagulation monitoring. These official statements provide clear requirements for administration and co-administration management.

Mechanism of Action

The mechanism of action for acetaminophen primarily involves pharmacologic activity within the central nervous system (CNS). The compound acts as a reducing agent on the cyclooxygenase (COX) enzyme system, selectively inhibiting COX activity in the brain and spinal cord. This interaction reduces the conversion of arachidonic acid into prostaglandins, leading to a decreased concentration of prostaglandins within the CNS. The resulting physiological consequence is a modification of central thermoregulatory and nociceptive signaling.

Acetaminophen also engages non-prostaglandin pathways. It is metabolized into the active compound AM404, which can activate the transient receptor potential vanilloid-1 (TRPV1) receptor and influence the uptake of the endocannabinoid anandamide. This mechanism modifies early molecular steps in pain transmission and influences signal transduction within targeted nociceptive pathways, contributing to the overall modulation of physiological responses.

Dosage and Administration Information

Administration Routes and Standard Dosing

Acetaminophen is administered via the oral route (tablets, suspensions), intravenous (IV) infusion, and rectal suppositories in clinical practice. The maximum recommended total daily dose across all routes for adults should not exceed 4000 mg in a 24-hour period.


Dosing Schedule and Frequency

For adult oral use, a standard single dose is typically 650 mg administered every 4 hours or 1000 mg every 6 hours, as needed. It is a requirement that a minimum interval of 4 to 6 hours must be maintained between doses to prevent excessive intake. Oral forms may be administered with or without food, and administration without food may result in a slightly faster onset of action.


Population-Specific and Duration Constraints

Dosing for pediatric patients (children over two years) is determined strictly by body weight, commonly ranging from 10 to 15 mg/kg per dose. Furthermore, the dosing interval must be extended in cases of severe hepatic or renal impairment to account for altered clearance. For non-prescription use, administration for pain should not exceed 10 days or 3 days for fever without further professional direction. A key administrative constraint is the explicit mandate not to use acetaminophen with any other combination product containing the same active ingredient.

Recent Clinical Evidence

Bufferin (Acetaminophen): Recent Clinical Evidence

Acetaminophen (paracetamol) is a widely used analgesic and antipyretic agent. Current research primarily focuses on refining its clinical applications, understanding its mechanism, and clarifying its safety profile, particularly in specific populations.


Efficacy and Chronic Pain

While acetaminophen is a primary recommendation for acute pain and fever reduction, recent systematic reviews have explored its role in chronic pain conditions. A review focusing on chronic osteoarthritis of the hip and knee found limited evidence to support the drug's efficacy in continuous, long-term dosing regimens. This suggests that the benefit of acetaminophen may be minimal or inconsistent for certain chronic pain over extended periods.


Safety Considerations in Pregnancy

Research has explored the association between prenatal acetaminophen exposure and the risk of neurodevelopmental disorders (NDDs) in children. Large observational studies have reported associations between frequent or prolonged use during pregnancy and potential effects on conditions like Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder. However, experts emphasize that these studies establish an association, not a causal relationship. Acetaminophen continues to be recommended by major professional organizations as the preferred over-the-counter option for fever and pain relief during pregnancy, as untreated fever and severe pain carry known risks to the mother and fetus. The consensus highlights the importance of using the lowest effective dose for the shortest necessary duration.


Pharmacokinetics and Safety Profile

Acetaminophen is metabolized primarily in the liver. Research confirms that taking more than the maximum recommended daily amount, especially in combination with alcohol, poses a risk of severe liver damage and is the leading cause of drug-induced acute liver failure. Studies also continue to evaluate the potential for rare, serious side effects, including severe skin reactions like Stevens-Johnson syndrome, reinforcing the need for careful use as directed.

Frequently Asked Questions (FAQ)

Common questions about Bufferin (Acetaminophen) (FAQ)


Q: What is the primary active ingredient in Bufferin?

According to the official product information, the primary active ingredient in Bufferin for pain relief and fever reduction is Acetaminophen (also known as paracetamol). It is classified as an analgesic (pain reliever) and an antipyretic (fever reducer). The specific formulation of the product determines the exact dose and other inactive ingredients.


Q: How long does it take for Bufferin (Acetaminophen) to start working?

Regulatory documents indicate that Acetaminophen is typically expected to begin working to relieve pain or reduce fever shortly after administration. The onset of relief is commonly observed within 30 minutes to one hour after taking a dose. However, individual results can vary.


Q: Can Bufferin (Acetaminophen) be used for a persistent headache?

Official information confirms that Acetaminophen is used for the temporary relief of minor aches and pains, including common headaches, such as tension-type headaches. However, regulatory warnings advise against self-medicating for pain lasting more than 10 days. If the headache is persistent, very severe, or unusual, medical attention may be needed.


Q: Is Bufferin (Acetaminophen) available without a prescription?

Yes, regulatory documents confirm that most Bufferin products containing only Acetaminophen are generally available over-the-counter (OTC). This classification is applied because the medicine is determined by regulatory bodies to be safe and effective when used as directed for its approved indications. Dosage and specific product strength may differ by package.


Q: What is the recommended period of use for Bufferin (Acetaminophen) before seeking medical advice?

Regulatory warnings advise against self-medicating with Acetaminophen for pain lasting more than 10 days, or for fever lasting more than 3 days, without professional guidance. These time limits are established for self-care. Exceeding these periods without a professional evaluation may mean the underlying condition requires specific medical attention.


Q: Does Bufferin (Acetaminophen) contain aspirin?

Historically, some Bufferin products contained aspirin (acetylsalicylic acid); however, products marketed specifically as 'Bufferin (Acetaminophen)' contain Acetaminophen as the active drug. The official product labeling specifies the contents of each package. For any specific product, the contents can be verified by reviewing the 'Active Ingredients' section on the product label.

How should Bufferin (Acetaminophen) be stored and disposed of?

Storage & Disposal Scope

Item Official Regulatory Information
Labeled storage temperature requirements Store at controlled room temperature, typically 20 C to 25 C (68 F to 77 F) [DailyMed].
Light/moisture protection requirements Protect from excess heat and moisture; do not store in the bathroom [MedlinePlus].
Packaging-related storage rules Keep in the original container, which must be kept tightly closed [MedlinePlus].
Disposal instructions Prioritize using a drug take-back program [FDA]. If unavailable, mix the medicine with an undesirable substance (e.g., dirt, coffee grounds) in a sealed bag before discarding in the trash [FDA].
Environmental disposal requirements Do not flush this medication down the toilet or pour it down the sink [MedlinePlus].
Child-protection storage requirements Must be kept out of the sight and reach of children [MedlinePlus].

Connection to the overall storage/disposal profile: Regulatory documents specify storage at room temperature, away from excessive moisture and heat, to ensure product stability and integrity. Mandatory instructions require the medication to be kept in its original, tightly closed packaging and secured away from children. Official disposal protocol emphasizes take-back programs or secure household disposal by mixing with waste material, and strictly prohibits flushing.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Bufferin (Acetaminophen) found in:

A-Z Index: